X4 Pharmaceuticals is “Driving progress for people living with rare immune disorders.” Headquartered in Boston, MA, X4Pharmaceuticals has been a partner of NNN for several years as they focus on creating and bringing to market therapies for individuals with rare immune system disorders with a focus on chronic neutropenia, fulfilling the critical need for options for our community.
Check out their Clinical Trial that is currently enroling candidates who qualify.
